[go: up one dir, main page]

WO2007025989A3 - Variants d'acides nucleiques dans les genes recepteurs similaires a toll lies a une immunite innee alteree - Google Patents

Variants d'acides nucleiques dans les genes recepteurs similaires a toll lies a une immunite innee alteree Download PDF

Info

Publication number
WO2007025989A3
WO2007025989A3 PCT/EP2006/065821 EP2006065821W WO2007025989A3 WO 2007025989 A3 WO2007025989 A3 WO 2007025989A3 EP 2006065821 W EP2006065821 W EP 2006065821W WO 2007025989 A3 WO2007025989 A3 WO 2007025989A3
Authority
WO
WIPO (PCT)
Prior art keywords
toll
nucleic acid
innate immunity
genes associated
acid variants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2006/065821
Other languages
English (en)
Other versions
WO2007025989A2 (fr
Inventor
Lieve Nuytinck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Europe NV SA
Original Assignee
Innogenetics NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics NV SA filed Critical Innogenetics NV SA
Priority to EP06806736A priority Critical patent/EP1931801A2/fr
Publication of WO2007025989A2 publication Critical patent/WO2007025989A2/fr
Publication of WO2007025989A3 publication Critical patent/WO2007025989A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne une méthode et un kit d'identification d'un sujet à risque ou présentant un signe lié à une immunité innée altérée. Cette invention a aussi pour objet la détermination de génotypes et/ou de niveaux de sérum du récepteur similaire à Toll .
PCT/EP2006/065821 2005-09-02 2006-08-30 Variants d'acides nucleiques dans les genes recepteurs similaires a toll lies a une immunite innee alteree Ceased WO2007025989A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06806736A EP1931801A2 (fr) 2005-09-02 2006-08-30 Variantes d'acides nucléiques acides dans les gènes de toll-like récepteurs associées avec une immunité innée modifiée

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05108074 2005-09-02
EP05108074.5 2005-09-02
US71752705P 2005-09-15 2005-09-15
US60/717,527 2005-09-15

Publications (2)

Publication Number Publication Date
WO2007025989A2 WO2007025989A2 (fr) 2007-03-08
WO2007025989A3 true WO2007025989A3 (fr) 2007-08-23

Family

ID=36128627

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/065821 Ceased WO2007025989A2 (fr) 2005-09-02 2006-08-30 Variants d'acides nucleiques dans les genes recepteurs similaires a toll lies a une immunite innee alteree

Country Status (2)

Country Link
EP (1) EP1931801A2 (fr)
WO (1) WO2007025989A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9580752B2 (en) 2008-12-24 2017-02-28 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8335652B2 (en) 2004-06-23 2012-12-18 Yougene Corp. Self-improving identification method
US11268149B2 (en) 2004-12-08 2022-03-08 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease
US10544459B2 (en) 2004-12-08 2020-01-28 Cedars-Sinai Medical Center Methods of using genetic variants for the diagnosis and treatment of inflammatory bowel disease
US12110555B2 (en) 2004-12-08 2024-10-08 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease
WO2008107377A2 (fr) * 2007-03-02 2008-09-12 Innogenetics N.V. Combinaisons de marqueurs de l'évaluation du risque de septicémie
EP2173896A2 (fr) * 2007-06-29 2010-04-14 Biomonitor A/S Procédé pronostique pour déterminer le caractère approprié d'un traitement biopharmaceutique
US20110229471A1 (en) 2008-11-26 2011-09-22 Cedars-Sinai Medical Center Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
US10633449B2 (en) 2013-03-27 2020-04-28 Cedars-Sinai Medical Center Treatment and reversal of fibrosis and inflammation by inhibition of the TL1A-DR3 signaling pathway
US10316083B2 (en) 2013-07-19 2019-06-11 Cedars-Sinai Medical Center Signature of TL1A (TNFSF15) signaling pathway
EP3430172A4 (fr) 2016-03-17 2019-08-21 Cedars-Sinai Medical Center Méthode de diagnostic d'une maladie inflammatoire chronique de l'intestin par l'intermédiaire de rnase t2
CN114182007B (zh) * 2021-12-08 2023-11-24 上海锐翌医学检验实验室有限公司 白塞病标志基因及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003050137A2 (fr) * 2001-12-11 2003-06-19 David Schwartz Mutations de recepteur de type toll 4

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003050137A2 (fr) * 2001-12-11 2003-06-19 David Schwartz Mutations de recepteur de type toll 4

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
BOCHUD P.-Y. ET AL.,: "cutting edge: a toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling", JOURNAL OF IMMUNOLOGY, vol. 170, 2003, pages 3451 - 3454, XP002377352 *
GOLDSTEIN D. R.: "toll-like receptors and other links between innate and acquired alloimmunity", CURRENT OPINION IN IMMUNOLOGY, vol. 16, 2004, pages 538 - 544, XP002377353 *
HAERTEL CH. ET. AL.,: "polymorphisms of genes involved in innate immunity: association with preterm delivery", MOLECULAR HUMAN REPRODUCTION, vol. 12, no. 10, 29 October 2004 (2004-10-29), pages 911 - 915, XP009065437 *
LAZARUS R. ET AL.: "Toll-like receptor 10 genetic variation is associated with asthma in two independent samples", AM. J. RESPIRATORY AND CRITICAL CARE MEDICINE, vol. 170, 2004, pages 594 - 600, XP002377355 *
LORENZ E ET AL: "RELEVANCE OF MUTATIONS IN THE TLR4 RECEPTOR IN PATIENTS WITH GRAM-NEGATIVE SEPTIC SHOCK", ARCHIVES OF INTERNAL MEDICINE, AMERICAN MEDICAL ASSOCIATION, CHICAGO, IL, US, vol. 162, no. 9, 15 May 2002 (2002-05-15), pages 1028 - 1032, XP008041705, ISSN: 0003-9926 *
LORENZ E. ET AL.,: "a novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection", INFECTION AND IMMUNITY, vol. 68, no. 11, November 2000 (2000-11-01), pages 6398 - 6401, XP002377354 *
MORRE S A ET AL: "Role of the toll-like receptor 4 Asp299Gly polymorphism in susceptibility to Candida albicans infection", JOURNAL OF INFECTIOUS DISEASES, CHICAGO, IL, US, vol. 186, 1 November 2002 (2002-11-01), pages 1377 - 1379, XP002904767, ISSN: 0022-1899 *
SCHROEDER N. W.J. & SCHUMANN R.R.: "single nucleotide polymorphisms of toll-like receptors and susceptibility to infectious disease", LANCET INFECT DIS., vol. 5, March 2005 (2005-03-01), pages 156 - 164, XP002377357 *
SUN J. ET AL.,: "sequence variants in toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk", J. NATIONAL CANCER INSTITUTE, vol. 97, no. 7, 6 April 2005 (2005-04-06), pages 525 - 532, XP002377356 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9580752B2 (en) 2008-12-24 2017-02-28 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy

Also Published As

Publication number Publication date
WO2007025989A2 (fr) 2007-03-08
EP1931801A2 (fr) 2008-06-18

Similar Documents

Publication Publication Date Title
WO2006089091A3 (fr) Procedes pour la detection de maladie residuelle minimale
WO2007025989A3 (fr) Variants d'acides nucleiques dans les genes recepteurs similaires a toll lies a une immunite innee alteree
WO2005106036A3 (fr) Methodes et compositions pour analyser des analytes
EP1288313A3 (fr) Système et méthode pour analyser des molécules d'acide nucléique
WO2006050499A3 (fr) Dosage de detection en une seule etape
WO2006007980A3 (fr) Esr1 et cancer cervical
WO2010002883A3 (fr) Procédés et dispositif pour analyse mono-moléculaire de génome entier
WO2009100188A3 (fr) Procédés de détection de l’événement de maïs das-59132
TW200745556A (en) Biomarkers for liver fibrotic injury
WO2008061213A3 (fr) Variations génétiques associées à des tumeurs
WO2007008276A3 (fr) Sondes a renouvellement et utilisation
WO2006117161A3 (fr) Nouvelles strategies d'etiquetage pour detection sensible d'analytes
WO2008135929A3 (fr) Procédé colorimétrique et coffret de détection de séquences d'acide nucléique spécifiques à l'aide de nanoparticules métalliques fonctionnalisées par oligonucléotides modifiés
WO2008136996A3 (fr) Polymorphismes géniques affectant les troubles associés à l'ace et utilisations
WO2005087951A3 (fr) Reactifs, procedes et kits utilise dans la desactivation d'acides nucleiques
WO2006052842A3 (fr) Methodes de diagnostic de syndromes myelodysplasiques (mds)
WO2007023148A3 (fr) Variants d'acides nucleiques dans le gene lbp associe a une immunite alteree innee
WO2010051214A8 (fr) Compositions et procédés de détection de mutations dans l'acide nucléique jak2
WO2007086980A3 (fr) Méthodes permettant de déterminer le risque de développer une coronaropathie
WO2006119326A3 (fr) Compositions de sondes/amorces oligonucleotidiques et procedes de detection de polynucleotides
WO2003072828A3 (fr) Polymorphismes geniques fc$g(y)riib humains permettant d'evaluer le developpement du lupus erythemateux systemique et compositions utilisees a cet effet
KR100520994B1 (en) Molecular marker associated with CMV resistance and use thereof
WO2008072217A3 (fr) Sondes d'acides nucléiques pour la détection d'espèces de levures et de champignons
WO2006026074A3 (fr) Genes determinant le phenotype atherosclerotique et methodes d'utilisation
TW200801200A (en) Methods for determining probability of an adverse or favorable reaction to a niacin receptor agonist

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006806736

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2006806736

Country of ref document: EP